CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 4 Open-market sale Chief Executive Officer sold 146,388 shares at an average $51.91 ($7,598,864)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Chief Executive Officer acquired 11,806 shares (option exercise)
- 4 Open-market sale General Counsel sold 32,500 shares at an average $61.72 ($2,005,875)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 40,000 shares at an average $61.70 ($2,467,941)
Page 18 of 69 · 1,363 filings